Published in

Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 4(23), p. 473-481, 2021

DOI: 10.1080/14656566.2021.2020250

Links

Tools

Export citation

Search in Google Scholar

Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO